ArticleBreast care (Basel, Switzerland)2018

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.

Franziska Würfel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.